DENTSPLY SIRONA 将来の成長

NasdaqGS:XRAY - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	3,907	219	368	N/A	12
12/31/2025	3,786	170	323	497	14
12/31/2024	3,813	-437	310	524	13
9/30/2024	3,900	-413	365	534	N/A
6/30/2024	3,896	-185	364	527	N/A
3/31/2024	3,940	-95	279	423	N/A
12/31/2023	3,965	-132	228	377	N/A
9/30/2023	3,936	-214	218	359	N/A
6/30/2023	3,936	-1,025	198	334	N/A
3/31/2023	3,931	-1,038	259	403	N/A
12/31/2022	3,922	-950	368	517	N/A
9/30/2022	4,042	-816	439	597	N/A
6/30/2022	4,135	345	499	660	N/A
3/31/2022	4,174	368	545	701	N/A
12/31/2021	4,231	411	515	657	N/A
9/30/2021	4,207	401	584	712	N/A
6/30/2021	4,062	370	634	748	N/A
3/31/2021	3,491	179	617	708	N/A
12/31/2020	3,339	-73	562	649	N/A
9/30/2020	3,371	-80	575	672	N/A
6/30/2020	3,438	-48	524	623	N/A
3/31/2020	3,957	84	479	594	N/A
12/31/2019	4,022	256	516	639	N/A
9/30/2019	3,977	162	397	536	N/A
6/30/2019	3,944	105	337	502	N/A
3/31/2019	3,976	-1,053	291	474	N/A
12/31/2018	3,986	-1,011	312	500	N/A
9/30/2018	4,018	-1,663	345	527	N/A
6/30/2018	4,098	-1,601	N/A	565	N/A
3/31/2018	4,049	-1,529	N/A	575	N/A
12/31/2017	3,993	-1,550	N/A	602	N/A
9/30/2017	3,899	-793	N/A	595	N/A
6/30/2017	3,844	-791	N/A	584	N/A
3/31/2017	3,873	365	N/A	645	N/A
12/31/2016	3,745	430	N/A	563	N/A
9/30/2016	3,420	382	N/A	467	N/A
6/30/2016	3,115	374	N/A	474	N/A
3/31/2016	2,791	312	N/A	433	N/A
12/31/2015	2,674	251	N/A	497	N/A
9/30/2015	2,722	277	N/A	564	N/A
6/30/2015	2,782	268	N/A	551	N/A
3/31/2015	2,849	314	N/A	561	N/A
12/31/2014	2,923	323	N/A	560	N/A
9/30/2014	2,957	313	N/A	527	N/A
6/30/2014	2,953	317	N/A	506	N/A
3/31/2014	2,949	314	N/A	446	N/A
12/31/2013	2,951	313	N/A	418	N/A

アナリストによる今後の成長予測

収入対貯蓄率: XRAYは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: XRAY今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: XRAY今後 3 年以内に収益を上げることが予想されます。

収益対市場: XRAYの収益 ( 1.2% ) US市場 ( 9% ) よりも低い成長が予測されています。

高い収益成長: XRAYの収益 ( 1.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: XRAYの自己資本利益率は、3年後には低くなると予測されています ( 16.6 %)。

DENTSPLY SIRONA 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

DENTSPLY SIRONA Inc. Revises Financial Guidance for the Fiscal Year 2024

Price target decreased by 7.0% to US$33.82

DENTSPLY SIRONA Inc. Provides Earnings Guidance for the Year 2024

Dentsply Sirona Inc. Provides Earnings Guidance for the Year 2024

Dentsply Sirona Inc. Provides Earnings Guidance for the Year Ended December 31, 2023

Price target decreased by 14% to US$35.42

Recent updates

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

DENTSPLY SIRONA Inc. Revises Financial Guidance for the Fiscal Year 2024

DENTSPLY SIRONA Inc. Provides Update on Byte Aligner Products

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Now 20% undervalued

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Upcoming dividend of US$0.16 per share

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

DENTSPLY Sirona Inc. Announces Resignation of Glenn Coleman as Executive Vice President, Effective from November 7, 2024

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Second quarter dividend of US$0.16 announced

Now 22% undervalued after recent price drop

Second quarter 2024 earnings: EPS misses analyst expectations

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

First quarter dividend of US$0.16 announced

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

DENTSPLY SIRONA Inc. Declares Quarterly Cash Dividend, Payable on July 12, 2024

Price target decreased by 7.0% to US$33.82

DENTSPLY SIRONA Inc. Provides Earnings Guidance for the Year 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

DENTSPLY SIRONA Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.14 per share

DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) dropped from FTSE All-World Index (USD)

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Fourth quarter dividend of US$0.14 announced

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Dentsply Sirona Inc. Provides Earnings Guidance for the Year 2024

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Dentsply Sirona Inc. Provides Earnings Guidance for the Year Ended December 31, 2023

Dentsply Sirona Declares Quarterly Cash Dividend, Payable on January 12, 2024

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Price target decreased by 14% to US$35.42

DENTSPLY SIRONA Inc. Announces Appointment of Mr. Brian Gladden as New Board Member, Effective January 1, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Dentsply Sirona Launches Suresmile™? Simulator

Price target decreased by 7.0% to US$41.17

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Upcoming dividend of US$0.14 per share at 1.6% yield

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

DENTSPLY SIRONA Inc. Declares Quarterly Cash Dividend Payable on October 13, 2023

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Upcoming dividend of US$0.14 per share at 1.4% yield

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

DENTSPLY SIRONA Inc. Appoints Jonathan J. Mazelsky as a Director

DENTSPLY SIRONA Inc. Declares Quarterly Cash Dividend, Payable on July 14, 2023

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

Independent Non-Executive Chairman notifies of intention to sell stock

Price target increased by 8.3% to US$44.00

DENTSPLY SIRONA Inc. Raises Earnings Guidance for the Full Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Upcoming dividend of US$0.14 per share at 1.5% yield

Insider recently sold US$157k worth of stock

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Price target increased by 8.0% to US$39.27

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

DENTSPLY SIRONA Inc. Updates Earnings Guidance for the Full Year 2022

DENTSPLY SIRONA Inc. Declares Quarterly Cash Dividend, Payable on January 13, 2023